Trial Profile
Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2015
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Musculoskeletal pain; Rheumatoid arthritis
- Focus Therapeutic Use
- 01 Dec 2015 Primary endpoint (change in average pain intensity, assessed by the brief pain inventory short form) has not been met according to the results published in The Journal of Rheumatology.
- 01 Dec 2015 Results published in The Journal of Rheumatology
- 25 Apr 2015 New trial record